Nouvelles publications

Passet, M., Kim, R., Gachet, S., Sigaux, F., Chaumeil, J., Galland, A., Sexton, T., Quentin, S., Hernandez, L., Larcher, L., Bergugnat, H., Ye, T., Karasu, N., Caye-Eude, A., Heizmann, B., Duluc, I., Chevallier, P., Rousselot, P., Huguet, F., … Clappier, E. (2022). Concurrent CDX2 cis-deregulation and UBTF-ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL. Blood, blood.2021014723. https://doi.org/10.1182/blood.2021014723
Bersuder, E., Terciolo, C., Lechevrel, M., Martin, E., Quesnelle, C., Freund, J.-N., Reimund, J.-M., & Gross, I. (2022). Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 146, 112543. https://doi.org/10.1016/j.biopha.2021.112543
Delhorme, J.-B., Bersuder, E., Terciolo, C., Vlami, O., Chenard, M.-P., Martin, E., Rohr, S., Brigand, C., Duluc, I., Freund, J.-N., & Gross, I. (2022). CDX2 controls genes involved in the metabolism of 5-fluorouracil and is associated with reduced efficacy of chemotherapy in colorectal cancer. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 147, 112630. https://doi.org/10.1016/j.biopha.2022.112630
Sirakov, M., & Plateroti, M. (2022). Thyroid Hormone Signaling and Function: News from Classical and Emerging Models. Cells, 11(3), 453. https://doi.org/10.3390/cells11030453
Priya, S., Kaur, E., Kulshrestha, S., Pandit, A., Gross, I., Kumar, N., Agarwal, H., Khan, A., Shyam, R., Bhagat, P., Prabhu, J. S., Nagarajan, P., Deo, S. V. S., Bajaj, A., Freund, J.-N., Mukhopadhyay, A., & Sengupta, S. (2021). CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors. Journal of Cell Science, 134(15), jcs258601. https://doi.org/10.1242/jcs.258601
Frau, C., Jamard, C., Delpouve, G., Guardia, G. D. A., Machon, C., Pilati, C., Nevé, C. L., Laurent-Puig, P., Guitton, J., Galante, P. A. F., Penalva, L. O., Freund, J.-N., de la Fouchardiere, C., & Plateroti, M. (2021). Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy. Cancer Research, 81(10), 2730–2744. https://doi.org/10.1158/0008-5472.CAN-20-2450
Galland, A., Gourain, V., Habbas, K., Güler, Y., Martin, E., Ebel, C., Tavian, M., Vallat, L., Chenard, M.-P., Mauvieux, L., Freund, J.-N., Duluc, I., & Domon-Dell, C. (2021). CDX2 expression in the hematopoietic lineage promotes leukemogenesis via TGFβ inhibition. Molecular Oncology. https://doi.org/10.1002/1878-0261.12982
Schleiss, C., Carapito, R., Fornecker, L.-M., Muller, L., Paul, N., Tahar, O., Pichot, A., Tavian, M., Nicolae, A., Miguet, L., Mauvieux, L., Herbrecht, R., Cianferani, S., Freund, J.-N., Carapito, C., Maumy-Bertrand, M., Bahram, S., Bertrand, F., & Vallat, L. (2021). Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia. Leukemia, 35(5), 1463–1474. https://doi.org/10.1038/s41375-021-01221-5
Julien, E., Biasch, K., El Omar, R., Freund, J.-N., Gachet, C., Lanza, F., & Tavian, M. (2021). Renin-angiotensin system is involved in embryonic emergence of hematopoietic stem/progenitor cells. Stem Cells (Dayton, Ohio), 39(5), 636–649. https://doi.org/10.1002/stem.3339
Godart, M., Frau, C., Farhat, D., Giolito, M. V., Jamard, C., Le Nevé, C., Freund, J.-N., Penalva, L. O., Sirakov, M., & Plateroti, M. (2021). Murine intestinal stem cells are highly sensitive to modulation of the T3/TRα1-dependent pathway. Development (Cambridge, England), 148(8), dev194357. https://doi.org/10.1242/dev.194357
El Omar, R., Julien, E., Biasch, K., Guffroy, B., Lioure, B., Vallat, L., Gross, I., Domon-Dell, C., Lanza, F., Gachet, C., Negroni, M., Freund, J.-N., & Tavian, M. (2021). CDX2 regulates ACE expression in blood development and leukemia cells. Blood Advances, 5(7), 2012–2016. https://doi.org/10.1182/bloodadvances.2020003563
Giolito, M. V., Claret, L., Frau, C., & Plateroti, M. (2021). A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells. JoVE (Journal of Visualized Experiments), 167, e61783. https://doi.org/10.3791/61783
Baroni, M., Yi, C., Choudhary, S., Lei, X., Kosti, A., Grieshober, D., Velasco, M., Qiao, M., Burns, S. S., Araujo, P. R., DeLambre, T., Son, M. Y., Plateroti, M., Ferreira, M. A. R., Hasty, P., & Penalva, L. O. F. (2021). Musashi1 Contribution to Glioblastoma Development via Regulation of a Network of DNA Replication, Cell Cycle and Division Genes. Cancers, 13(7), 1494. https://doi.org/10.3390/cancers13071494
Sirakov, M., Claret, L., & Plateroti, M. (2021). Thyroid Hormone Nuclear Receptor TRα1 and Canonical WNT Pathway Cross-Regulation in Normal Intestine and Cancer. Frontiers in Endocrinology, 12, 725708. https://doi.org/10.3389/fendo.2021.725708
Gourain, V., Duluc, I., Domon-Dell, C., & Freund, J.-N. (2021). A Core Response to the CDX2 Homeoprotein During Development and in Pathologies. Frontiers in Genetics, 12, 744165. https://doi.org/10.3389/fgene.2021.744165